Known generically as isotretinoin, Accutane is a medicine manufactured by Hoffmann La Roche. Accutane gained U.S. Food and Drug Administration (FDA) approval in 1982 to treat severe acne.
The American Journal of Gastroenterology published a study in March 2010 about use of drugs containing isotretinoin, such as Accutane, and the risk of inflammatory bowel disease. In their results, the researchers noted a four percent increase in the risk of developing ulcerative colitis when using drugs like Accutane. They also noticed that in those study participants who used drugs like Accutane for longer durations, especially longer than two months, and in higher dosages, the risk of ulcerative colitis, a type of inflammatory bowel disease, increased significantly.
Accutane & Ulcerative Colitis
A kind of inflammatory bowel disease, ulcerative colitis has been associated with Accutane use, especially in high dosages. Signs of ulcerative colitis include pain and cramping of the abdomen, abnormal sounds emanating from the abdominal region, bloody stools, fever, and weight loss.
Carey Danis & Lowe is Here to Help
If you have used Accutane, and have noticed any of the symptoms mentioned above, it is important to immediately consult with your prescribing physician.
As a national law firm based in St. Louis, Carey Danis & Lowe represents victims of defective drugs, such as Accutane. We encourage you to explore your legal options with one of our Accutane lawyers. Our initial consultations are free.
Carey Danis & Lowe Accutane attorneys are highly experienced in handling personal injury claims and pharmaceutical litigation involving defective drugs. We work closely alongside our team of medical professional and our clients to develop strong court cases.
For more information about Accutane and inflammatory bowel disease, and for assistance with filing an Accutane lawsuit, contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim.
Stay current on personal injury litigation news by reading the Carey Danis & Lowe blog.